The prescription-only IB-Stim device is a small, battery-powered electrical nerve stimulator that is placed behind the ear and emits low-frequency electrical pulses to stimulate branches of cranial nerves, a technique believed to provide pain relief. The single-use device is worn for five days before being replaced, and can be used consistently for up to three weeks.
The FDA’s clearance came after a clinical study showed that adolescent IBS patients who used the device to treat their abdominal pain experienced significant decreases in their pain over the course of three weeks. IB-Stim can be used in tandem with a patient’s existing medication regimen for IBS-related chronic abdominal pain.
More articles about health IT:
Cleveland Clinic study finds electronic inhaler usage reduces COPD-related hospitalizations
Most health system CFOs lack agreeable cooperation with CIOs, survey finds
Google’s 5 latest health-related job openings
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.